ABT FINANCIAL STATEMENTS

Abbott Laboratories — balance sheet, income statement and cash flow trends

ABTAbbott Laboratories

🇺🇸 USA · US · Healthcare · Medical Devices

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue45.1 B $+6.6%

Gross Profit25.4 B $+16.9%

Operating Income8.2 B $+14.2%

EBITDA11.2 B $+0.6%

Net Income6.3 B $-53.5%

Peer Comparison· Medical Devices

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
ABT	6.6%	56.4%	24.8%	13.9%
SHL	-0.3%	38.0%	19.1%	9.1%
PHIA	-1.9%	45.2%	15.4%	5.5%
COH	2.0%	73.0%	24.0%	14.6%
Industry median	7.4%	58.9%	5.2%	-5.7%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
ABT	6.6%	56.4%	24.8%	13.9%
SYK	8.8%	63.7%	24.4%	13.2%
MDT	8.4%	65.0%	26.7%	13.2%
BSX	17.4%	70.4%	26.6%	17.2%
EW	13.8%	78.0%	22.5%	17.3%
GEHC	0.8%	42.5%	17.0%	7.5%
Industry median	7.4%	58.9%	5.2%	-5.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity52.1 B $47%
Current Liabilities18.4 B $17%
Long-term Liabilities39.4 B $36%

Key Figures

YoY change

Total Assets110.4 B $+35.6%

Total Liabilities57.7 B $+78.3%

Total Equity52.1 B $+6.7%

Cash & ST Investments7.3 B $+6.6%

Total Debt34 B $+157.1%

Net Debt27.2 B $+306.0%

Peer Comparison· Medical Devices

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
ABT	1.39	65.4%	2.39	47.1%
SHL	1.10	84.1%	3.04	40.6%
PHIA	1.32	71.1%	2.03	41.8%
COH	2.46	22.1%	0.42	69.4%
Industry median	3.28	44.7%	0.82	49.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
ABT	1.39	65.4%	2.39	47.1%
SYK	2.11	66.3%	1.99	49.6%
MDT	2.13	56.5%	1.93	53.2%
BSX	1.90	42.6%	1.73	58.3%
EW	4.42	6.8%	-2.09	77.5%
GEHC	1.17	99.1%	2.44	28.7%
Industry median	3.28	44.7%	0.82	49.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow9.5 B $+5.7%

Capital Expenditures2.1 B $-9.0%

Free Cash Flow7.4 B $+10.8%

Dividends Paid-4.2 B $-207.2%

Peer Comparison· Medical Devices

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
ABT	21.0%	16.3%	4.6%	150.8%
SHL	12.2%	8.7%	3.5%	134.0%
PHIA	13.0%	10.8%	2.2%	236.4%
COH	11.2%	8.5%	2.7%	76.6%
Industry median	7.2%	1.5%	4.1%	76.6%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
ABT	21.0%	16.3%	4.6%	150.8%
SYK	21.3%	18.1%	3.2%	161.1%
MDT	20.2%	14.9%	5.2%	152.7%
BSX	21.1%	16.7%	4.4%	122.2%
EW	21.6%	17.3%	4.3%	124.3%
GEHC	10.2%	7.6%	2.5%	134.8%
Industry median	7.2%	1.5%	4.1%	76.6%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ABT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.